Ignite Creation Date:
2024-05-06 @ 6:29 PM
Last Modification Date:
2024-10-26 @ 2:49 PM
Study NCT ID:
NCT05679479
Status:
COMPLETED
Last Update Posted:
2024-05-28
First Post:
2023-01-10
Brief Title:
Study on the Safety and Efficacy of Meplazumab for Injection in Severe Patients With COVID-19
Sponsor:
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd
Organization:
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| COVID-19 |
Keywords: